Key Publications April 13, 2016

Novel approaches in primary cardiovascular disease prevention: The HOPE-3 Trial rationale, design, and participants’ baseline characteristics.

Can J Cardiol. 2016;32:311-8

Lonn E, Bosch J, Pogue J, Avezum A, Chazova I, Dans A et al.